Cardiac drug sales: Who’s on top & who’s slipping

AstraZeneca led the pack of pharmaceutical companies for revenue from cardiovascular drugs in 2014, according to a PMLive analysis. But of the top 10 companies, only Bayer and Takeda posted growth in sales that year. Here are figures for the leading companies.

Candace Stuart, Contributor

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.